Vinpocetine for Parkinson's disease
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests if adding vinpocetine to standard levodopa treatment can help Parkinson's disease patients. It aims to see if this combination improves symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 50 years old
- You have been diagnosed with Parkinson's disease
- You are already taking levodopa for Parkinson's
- You are not pregnant or breastfeeding, and use effective birth control if needed
- You do not have heart disease, bleeding disorders, active cancer, or a history of brain surgery for Parkinson's
- You are not taking anti-inflammatory drugs or addicted to alcohol or drugs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if metformin, a diabetes drug, can help people with Parkinson's disease. It may improve symptoms or slow progression.
This trial tests if a low dose of carbon monoxide (HBI-002) is safe and helpful for people with Parkinson's disease. It requires specific health criteria and stable Parkinson's medication.
This trial tests whether injecting special cells into the brain can improve Parkinson's symptoms. It is for people who have had Parkinson's for at least 5 years, take levodopa but still have times when the medication wears off or causes uncontrolled movements.
This study uses a special test to look at dopamine levels in the brain of people with Parkinson's disease. It may help doctors understand the disease better and could lead to better treatments.
This trial tests a new treatment made from special cells injected into the brain to help people with Parkinson's disease who take levodopa but still have complications like wearing off or involuntary movements.
This study tests a treatment called Vibrotactile Coordinated Reset (VCR) to see if it can help people with early-stage Parkinson’s disease. It includes virtual check-ins and likely uses brain and finger sensation testing to monitor effects over time.
Hear when a new Parkinson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.